Seattle Genetics (SGEN) Tops Q2 EPS by 9c
Tweet
Share
E-mailGet Alerts SGEN Hot Sheet
Price: $228.74 --0%
Financial Fact:
Revenue from collaboration and license agreements: 23.97M
Today's EPS Names:
SQZB, RENO, LUNA, More
Financial Fact:
Revenue from collaboration and license agreements: 23.97M
Today's EPS Names:
SQZB, RENO, LUNA, More
Join SI Premium – FREE
Seattle Genetics (NASDAQ: SGEN) reported Q2 EPS of ($0.23), $0.09 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $95.4 million versus the consensus estimate of $94.14 million.
For earnings history and earnings-related data on Seattle Genetics (SGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- XPeng Inc. (XPEV) Misses Q2 EPS by 100c ; Provides Outlook
- JPMorgan Reiterates Overweight Rating on Dixon Technologies India Ltd (DIXON:IN)
- Guggenheim Reiterates Neutral Rating on Snowflake Inc. (SNOW)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
